Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions

British Journal of Dermatology

Volumn 166, Issue 3, 2012, Pages 491-497

  Kokolakis, G ^a,b   Giannikaki, E ^a   Stathopoulos, E ^a   Avramidis, G ^a   Tosca, A D ^a   Kruger Krasagakis S ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

apoptosis; caspase independent; infliximab; keratinocyte; psoriasis

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; SKIN BIOPSY; SKIN DEFECT; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; ANTIBODIES, MONOCLONAL; APOPTOSIS; APOPTOSIS INDUCING FACTOR; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BIOPSY; CASPASES; DERMATOLOGIC AGENTS; DOWN-REGULATION; EPIDERMIS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MIDDLE AGED; NF-KAPPA B; PSORIASIS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84857639526     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10689.x     Document Type: Article

References (21)

1. Lowes MA, Bowcock AM, Krueger JG,. Pathogenesis and therapy of psoriasis. Nature 2007; 445: 866-73.
2. Sands BE,. Why do anti-tumor necrosis factor antibodies work in Crohn's disease? Rev Gastroenterol Disord 2004; 4 (Suppl. 3): S10-17. (Pubitemid 39600213)
3. Tak PP,. Effects of infliximab treatment on rheumatoid synovial tissue. J Rheumatol Suppl 2005; 74: 31-4. (Pubitemid 40365778)
4. Wrone-Smith T, Mitra RS, Thompson CB, et al. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am J Pathol 1997; 151: 1321-9. (Pubitemid 27479762)
5. Laporte M, Galand P, Fokan D, et al. Apoptosis in established and healing psoriasis. Dermatology 2000; 200: 314-16. (Pubitemid 30451579)
6. Lavrik I, Golks A, Krammer PH,. Death receptor signaling. J Cell Sci 2005; 118: 265-7. (Pubitemid 40277339)
7. Tait SW, Green DR,. Caspase-independent cell death: leaving the set without the final cut. Oncogene 2008; 27: 6452-61.
8. Pradelli LA, Beneteau M, Ricci JE,. Mitochondrial control of caspase-dependent and -independent cell death. Cell Mol Life Sci 2010; 67: 1589-97.
9. Riley T, Sontag E, Chen P, et al. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9: 402-12. (Pubitemid 351574202)
10. Brown KD, Claudio E, Siebenlist U,. The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res Ther 2008; 10: 212-25.
11. Krüger-Krasagakis S, Galanopoulos VK, Giannikaki L, et al. Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis. Br J Dermatol 2006; 154: 460-6. (Pubitemid 43382653)
12. Kokolakis G, Panagis L, Stathopoulos E, et al. From the protein to the graph: how to quantify immunohistochemistry staining of the skin using digital imaging. J Immunol Methods 2008; 331: 140-6.
13. Takahashi H, Manabe A, Ishida-Yamamoto A, et al. Aberrant expression of apoptosis-related molecules in psoriatic epidermis. J Dermatol Sci 2002; 28: 187-97. (Pubitemid 34242653)
14. Malaviya R, Sun Y, Tan JK, et al. Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients. J Am Acad Dermatol 2006; 55: 590-7. (Pubitemid 44436644)
15. Bedini C, Nasorri F, Girolomoni G, et al. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function. Br J Dermatol 2007; 157: 249-58. (Pubitemid 47083831)
16. Avramidis G, Krüger-Krasagakis S, Krasagakis K, et al. The role of endothelial cell apoptosis in the effect of etanercept in psoriasis. Br J Dermatol 2010; 163: 928-34.
17. Markham T, Mathews C, Rogers S, et al. Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy. Br J Dermatol 2006; 155: 1191-6. (Pubitemid 44729994)
18. Banno T, Gazel A, Blumenberg M,. Pathway-specific profiling identifies the NF-kappa B-dependent tumor necrosis factor alpha-regulated genes in epidermal keratinocytes. J Biol Chem 2005; 280: 18973-80. (Pubitemid 41379601)
19. Lizzul PF, Aphale A, Malaviya R, et al. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept. J Invest Dermatol 2005; 124: 1275-83. (Pubitemid 40847416)
20. Green DR, Kroemer G,. Cytoplasmic functions of the tumour suppressor p53. Nature 2009; 458: 1127-30.
21. Stambolsky P, Weisz L, Shats I, et al. Regulation of AIF expression by p53. Cell Death Differ 2006; 13: 2140-9. (Pubitemid 44742697)